Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment

Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment

Voriconazole plasma concentrations (PC) are highly variable, particularly in children. Dose recommendations in 2–12-year-old patients changed in 2012. Little data on therapeutic drug monitoring (TDM) after these new recommendations are available. We aimed to evaluate voriconazole monitoring in child...

Full description

Bibliographic Details
Main Authors: José María Valle-T-Figueras, Berta Renedo Miró, Maria Isabel Benítez Carabante, Cristina Díaz-de-Heredia, Jaume Vima Bofarull, Natalia Mendoza-Palomar, Maria Teresa Martín-Gómez, Pere Soler-Palacín
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Fungi
Subjects:
paediatric fungal infections
antifungal treatment
therapeutic drug monitoring
voriconazole
children
inflammation
Online Access:https://www.mdpi.com/2309-608X/7/6/456

Internet

https://www.mdpi.com/2309-608X/7/6/456

Similar Items